3 Stocks I Saw on T...
Health Care: Drugs
Cubist Pharmaceuticals Inc. (CBST: NASDAQ)
$39.93 0.26 | 0.66%
06/04/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 197.62M | 372.97M | 157.32M | 409.02M |
| Receivables | 87.80M | 61.20M | 57.83M | 43.16M |
| Inventories | 34.89M | 23.82M | 25.50M | 21.96M |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1.04B | 1.02B | 450.03M | 533.01M |
| Property, Plant & Equipment, Gross | 225.58M | 138.68M | 116.38M | 104.81M |
| Accumulated Depreciation & Depletion | 57.16M | 56.25M | 48.00M | 37.99M |
| Property, Plant & Equipment, Net | 168.42M | 82.43M | 68.38M | 66.82M |
| Intangibles | 174.98M | 207.84M | 210.78M | 19.72M |
| Other Non-Current Assets | 378.64M | 47.18M | 185.46M | 15.66M |
| Total Non-Current Assets | 844.18M | 398.91M | 527.65M | 183.58M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 1.89B | 1.42B | 977.68M | 716.59M |
| Accounts Payable | 32.58M | 23.48M | 18.66M | 11.58M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 71.00M | 30.99M | 20.00M | 0.00 |
| Total Current Liabilities | 252.38M | 150.64M | 126.21M | 81.48M |
| Long Term Debt | 454.25M | 435.80M | 245.39M | 300.00M |
| Deferred Income Taxes | 143.18M | 82.83M | 31.20M | 0.00 |
| Other Non-Current Liabilities | 237.79M | 82.46M | 104.23M | 23.14M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 835.21M | 601.09M | 380.82M | 323.14M |
| Total Liabilities | 1.09B | 751.73M | 507.03M | 404.62M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 799.86M | 663.42M | 470.64M | 311.97M |
| Common Par | 63.00K | 59.00K | 0.00 | 57.00K |
| Additional Paid In Capital | 904.28M | 800.62M | 702.25M | 578.14M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -104.30M | -137.32M | -238.98M | -266.22M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | -185.00K | 71.00K | 7.38M | 0.00 |
| Total Capitalization | 1.25B | 1.10B | 716.03M | 611.97M |
| Total Equity | 799.86M | 663.42M | 470.64M | 311.97M |
| Total Liabilities & Stock Equity | 1.89B | 1.42B | 977.68M | 716.59M |
| Total Common Shares Outstanding | 62.64M | 59.34M | 57.98M | 57.55M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 60.84M | 58.80M | 57.75M | 56.65M |
| Diluted Weighted Shares Outstanding | 62.94M | 62.66M | 68.38M | 67.96M |
| Number of Employees | 669 | 638 | 600 | 554 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with CBST
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- UserGFNN Stockdiagnostics 6
- ContributorStocks At New 52-Week Highs...
- ContributorTop-Rated Biotechnology Stocks
- ContributorEarnings Short Squeeze Play...
- ContributorStocks At New 52-Week Highs...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ProJoel Greenblatt - Gotham Ca...
- ContributorEarnings Short Squeeze Play...
Latest CBST Headlines from TheStreet
- Upgrades Roundup: TXT, CBST, BK, MCP, AVP, LFL, SHO, BPI 04.23.12 | 06:04 am
- Cubist Pharmaceuticals Inc. Stock Upgraded (CBST) 04.20.12 | 05:04 am
- 5 Stocks Poised to Pop on Earnings 04.18.12 | 07:04 am
- Cubist Stock Hits New 52-Week High (CBST) 03.26.12 | 11:03 am
- Cubist Stock Hits New 52-Week High (CBST) 03.09.12 | 10:03 am
- Cubist Reaches New 52-Week High (CBST) 02.22.12 | 03:02 pm
- Cubist Stock Hits New 52-Week High (CBST) 02.03.12 | 10:02 am
- TheStreet Ratings Top 10 Rating Changes 01.23.12 | 12:01 pm
- Cubist Pharmaceuticals Inc. Stock Downgraded (CBST) 01.23.12 | 05:01 am
- 5 Stocks Set to Soar on Bullish Earnings 01.18.12 | 03:01 pm
Press Releases for CBST
- Cubist Pharmaceuticals Marks 20th Anniversary By Making Its Largest-Ever Commitment To STEM Programs - Business Wire 05.16.12 | 09:05 am
- Cubist Pharmaceuticals To Present At May Investor Conference - Business Wire 05.07.12 | 10:05 am
- Cubist Announces Positive Results From ENTEREG® Phase 4 Study In Patients Undergoing Radical Cystectomy - Business Wire 04.17.12 | 05:04 pm
- Cubist Pharmaceuticals To Announce Q112 Financial Results On Wednesday, April 18th, 2012 - Business Wire 04.02.12 | 10:04 am
- Senator Scott Brown And Cubist Pharmaceutical President And CEO Michael Bonney (right) And Steven Gilman, Executive Vice President, Research & Development And Chief Scientific Officer. - Business Wire 03.16.12 | 12:03 pm
- Cubist Pharmaceuticals Appoints Jane Henney To Board Of Directors - Business Wire 03.09.12 | 08:03 am
- Cubist Pharmaceuticals To Present At February/March Investor Conferences - Business Wire 02.20.12 | 11:02 am
- Cubist Pharmaceuticals Appoints Alison Lawton To Board Of Directors - Business Wire 02.16.12 | 08:02 am
- Cubist Receives CUBICIN Paragraph IV Notice Letter - Business Wire 02.09.12 | 07:02 am
- Cubist Pharmaceuticals Reports 2011 Fourth Quarter And Full Year Financial Results - Business Wire 01.19.12 | 04:01 pm
Partner Headlines for CBST
- After Hours Most Active for Jun 1, 2012 : BAC, QQQ, MSFT, JPM, KITD, SWK, WFC, WMB, MET, STX, CBST, INTC - NASDAQ 06.01.12 | 08:06 pm
- The Definitive Biotech ETF Guide (IBB, XBI, FBT) - Benzinga 05.21.12 | 01:05 pm
- Medical Stocks Forming Bases Amid Market Sell-Off - Investor's Business Daily 05.18.12 | 06:05 pm
- Big Pharma Abandons Antibiotics: An Opening For Small Biotech - Seeking Alpha 05.13.12 | 09:05 am
- 2 Low-Growth Pharma Behemoths: Merck, J&J - Seeking Alpha 05.01.12 | 09:05 am
- Kinetics Hedge Fund's Top Undervalued Picks - Seeking Alpha 03.23.12 | 05:03 pm
- Alnylam Delivers In-Line Numbers - Analyst Blog - Zacks 02.13.12 | 10:02 am
- 10 Stocks That Made New Highs On Friday: Hedging Costs - Seeking Alpha 01.15.12 | 07:01 am
- Cubist's Preliminary Sales Impress - Analyst Blog - Zacks 01.11.12 | 10:01 am
- Alnylam States Preclinical Data - Analyst Blog - Zacks 12.30.11 | 04:12 pm
